It doesn’t matter who approached who. All that matters is we are in their tier one program. If our drug has potential it needs to be tested ASAP along with all the other drugs that have potential, the vast majority of which wouldn’t be tier one candidates. Anything less would be irresponsible.
The tier one selection would be up to Doherty not PTX. It’s announcement worth sharing because it indicates the quality of our science. But it’s not the main game as far as PTX is concerned and it’s a long shot. Nevertheless, who knows what might come out of it.
PTX Price at posting:
6.6¢ Sentiment: Buy Disclosure: Held
